Biosergen AB 8N1.F Stock
0.02 EUR
{{ price }}
-0.840335%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
3.62M EUR
LOW - HIGH [24H]
0.02
-
0.02 EUR
VOLUME [24H]
250 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 EUR
Biosergen AB Price Chart
Biosergen AB 8N1.F Financial and Trading Overview
| Biosergen AB stock price | 0.02 EUR |
| Previous Close | 0.09 EUR |
| Open | 0.09 EUR |
| Bid | 0.09 EUR x N/A |
| Ask | 0.1 EUR x N/A |
| Day's Range | 0.09 - 0.09 EUR |
| 52 Week Range | 0.08 - 0.55 EUR |
| Volume | 70 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 4.02M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8N1.F Valuation Measures
| Enterprise Value | 3.82M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Biosergen AB Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -76.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.55 EUR |
| 52 Week Low | 0.08 EUR |
| 50-Day Moving Average | 0.1 EUR |
| 200-Day Moving Average | 0.17 EUR |
8N1.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 42.43M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 87.49% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -114.037% |
| Return on Equity (ttm) | -245.090% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -280000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.293 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Biosergen AB
| Country | Germany |
| State | N/A |
| City | Solna |
| Address | Fogdevreten 2 |
| ZIP | 171 65 |
| Phone | 46 4 52 08 02 470 |
| Website | https://biosergen.net |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of invasive fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
Q&A For Biosergen AB Stock
What is a current 8N1.F stock price?
Biosergen AB 8N1.F stock price today per share is 0.02 EUR.
How to purchase Biosergen AB stock?
You can buy 8N1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biosergen AB?
The stock symbol or ticker of Biosergen AB is 8N1.F.
Which industry does the Biosergen AB company belong to?
The Biosergen AB industry is Biotechnology.
How many shares does Biosergen AB have in circulation?
The max supply of Biosergen AB shares is 153.46M.
What is Biosergen AB Price to Earnings Ratio (PE Ratio)?
Biosergen AB PE Ratio is now.
What was Biosergen AB earnings per share over the trailing 12 months (TTM)?
Biosergen AB EPS is -0.03 EUR over the trailing 12 months.
Which sector does the Biosergen AB company belong to?
The Biosergen AB sector is Healthcare.